Bioray Biotech Co., Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 88.86 million compared to TWD 62.71 million a year ago. Net income was TWD 0.935 million compared to net loss of TWD 6.59 million a year ago.

Basic earnings per share from continuing operations was TWD 0.03 compared to basic loss per share from continuing operations of TWD 0.25 a year ago. Diluted earnings per share from continuing operations was TWD 0.03 compared to diluted loss per share from continuing operations of TWD 0.25 a year ago.